Literature DB >> 12140753

The cyclin H/cdk7/Mat1 kinase activity is regulated by CK2 phosphorylation of cyclin H.

Eberhard Schneider1, Sabine Kartarius, Norbert Schuster, Mathias Montenarh.   

Abstract

Cyclin dependent kinases are regulated by phosphorylation and dephosphorylation of the catalytic cdk subunits, by assembly with specific cyclins and by specific inhibitor molecules. Recently, it turned out that cyclins are also phosphoproteins, which means that they are also potential targets for a regulation by phosphorylation and dephosphorylation. Here, we show that cyclin H was phosphorylated by protein kinase CK2. Like most other CK2 substrates cyclin H was much better phosphorylated by the CK2 holoenzyme than by the alpha-subunit alone. By using point mutants derived from the cyclin H sequence we mapped the CK2 phosphorylation site at threonine 315 at the C-terminal end of cyclin H. Phosphorylation at this position had no influence on the assembly of the cyclin H/cdk7/Mat1 complex. However, phosphorylation at amino acid 315 of cyclin H turned out to be critical for a full cyclin H/cdk7/Mat1 kinase activity when the CTD peptide of RNA polymerase II or cdk2 was used as a substrate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140753     DOI: 10.1038/sj.onc.1205690

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Down-regulation of CK2 activity results in a decrease in the level of cdc25C phosphatase in different prostate cancer cell lines.

Authors:  Carolin C Schneider; Claudia Götz; Andrea Hessenauer; Jürgen Günther; Sabine Kartarius; Mathias Montenarh
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

2.  The human adenovirus type 5 E1B 55-kilodalton protein is phosphorylated by protein kinase CK2.

Authors:  Wilhelm Ching; Thomas Dobner; Emre Koyuncu
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

3.  Activation of pre-mRNA splicing by human RNPS1 is regulated by CK2 phosphorylation.

Authors:  Janeen H Trembley; Sawako Tatsumi; Eiji Sakashita; Pascal Loyer; Clive A Slaughter; Hitoshi Suzuki; Hitoshi Endo; Vincent J Kidd; Akila Mayeda
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 4.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

5.  Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer.

Authors:  Chen Peng; Yansong Yang; Li Ji; Panpan Yang; Xiaoqing Yang; Yuquan Zhang
Journal:  Cancer Cell Int       Date:  2020-07-16       Impact factor: 5.722

Review 6.  CDK7 inhibitors as anticancer drugs.

Authors:  Georgina P Sava; Hailing Fan; R Charles Coombes; Lakjaya Buluwela; Simak Ali
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

7.  Identification of recurrent fusion genes across multiple cancer types.

Authors:  Yan-Ping Yu; Peng Liu; Joel Nelson; Ronald L Hamilton; Rohit Bhargava; George Michalopoulos; Qi Chen; Jun Zhang; Deqin Ma; Arjun Pennathur; James Luketich; Michael Nalesnik; George Tseng; Jian-Hua Luo
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.